Nature Communications (May 2022)

Synthetic lethality between TP53 and ENDOD1

  • Zizhi Tang,
  • Ming Zeng,
  • Xiaojun Wang,
  • Chang Guo,
  • Peng Yue,
  • Xiaohu Zhang,
  • Huiqiang Lou,
  • Jun Chen,
  • Dezhi Mu,
  • Daochun Kong,
  • Antony M. Carr,
  • Cong Liu

DOI
https://doi.org/10.1038/s41467-022-30311-w
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

The authors uncover synthetic lethality between TP53 and ENDOD1, which contains an atypical endonuclease domain. Co-depleted G1 cells accumulate single stranded DNA and die. Combined with xenograft data the work identifies ENDOD1 as a potential cancer-specific SL drug discovery target.